[
    [
        {
            "time": "",
            "original_text": "智飞生物：公司的重组带状疱疹疫苗（CHO细胞）现处于临床前研究",
            "features": {
                "keywords": [
                    "智飞生物",
                    "重组带状疱疹疫苗",
                    "CHO细胞",
                    "临床前研究"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "智飞生物：公司的重组带状疱疹疫苗（CHO细胞）现处于临床前研究",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "智飞生物：注射用母牛分枝杆菌（商品名：微卡?）属于药品",
            "features": {
                "keywords": [
                    "智飞生物",
                    "注射用母牛分枝杆菌",
                    "微卡",
                    "药品"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "智飞生物：注射用母牛分枝杆菌（商品名：微卡?）属于药品",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        }
    ]
]